These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3322846)
21. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant. Pawson R; Potter MN; Theocharous P; Lawler M; Garg M; Yin JA; Rezvani K; Craddock C; Rassam S; Prentice HG Br J Haematol; 2001 Dec; 115(3):622-9. PubMed ID: 11736947 [TBL] [Abstract][Full Text] [Related]
22. Outcome after allogeneic bone marrow transplant for leukemia in older adults. Ringdén O; Horowitz MM; Gale RP; Biggs JC; Gajewski J; Rimm AA; Speck B; Veum-Stone JA; de Witte T; Bortin MM JAMA; 1993 Jul; 270(1):57-60. PubMed ID: 8510297 [TBL] [Abstract][Full Text] [Related]
23. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético. Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172 [TBL] [Abstract][Full Text] [Related]
24. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Marks DI; Cullis JO; Ward KN; Lacey S; Syzdlo R; Hughes TP; Schwarer AP; Lutz E; Barrett AJ; Hows JM; Batchelor JR; Goldman JM Ann Intern Med; 1993 Aug; 119(3):207-14. PubMed ID: 8391772 [TBL] [Abstract][Full Text] [Related]
25. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation. van der Straaten HM; Fijnheer R; Dekker AW; Nieuwenhuis HK; Verdonck LF Br J Haematol; 2001 Jul; 114(1):31-5. PubMed ID: 11472341 [TBL] [Abstract][Full Text] [Related]
26. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors]. Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754 [TBL] [Abstract][Full Text] [Related]
27. The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation. Frassoni F; Scarpati D; Bacigalupo A; Vitale V; Corvo R; Miceli S; Gualandi F; Occhini D; Clavio M; van Lint MT Br J Haematol; 1989 Oct; 73(2):211-6. PubMed ID: 2684259 [TBL] [Abstract][Full Text] [Related]
28. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia. Locatelli F; Pession A; Comoli P; Bonetti F; Giorgiani G; Zecca M; Taibi RM; Mongini ME; Ambroselli F; de Stefano P; Severi F; Paolucci G Br J Haematol; 1996 Jan; 92(1):49-54. PubMed ID: 8562410 [TBL] [Abstract][Full Text] [Related]
29. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428 [TBL] [Abstract][Full Text] [Related]
31. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [TBL] [Abstract][Full Text] [Related]
32. Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults. Barker JN; Davies SM; DeFor TE; Burns LJ; McGlave PB; Miller JS; Weisdorf DJ Br J Haematol; 2002 Jul; 118(1):101-7. PubMed ID: 12100132 [TBL] [Abstract][Full Text] [Related]
33. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation. De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252 [TBL] [Abstract][Full Text] [Related]
34. Chronic myeloid leukaemia treated by allogeneic bone marrow transplantation from histocompatible sibling donors--an invariably fatal malignancy rendered highly curable. Szer J; Sheridan WP Aust N Z J Med; 1991 Aug; 21(4):408-13. PubMed ID: 1953529 [TBL] [Abstract][Full Text] [Related]
35. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434 [TBL] [Abstract][Full Text] [Related]
36. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937 [TBL] [Abstract][Full Text] [Related]
37. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM). Michallet M; Tanguy ML; Socié G; Thiébaut A; Belhabri A; Milpied N; Reiffers J; Kuentz M; Cahn JY; Blaise D; Demeocq F; Jouet JP; Michallet AS; Ifrah N; Vilmer E; Molina L; Michel G; Lioure B; Cavazzana-Calvo M; Pico JL; Sadoun A; Guyotat D; Attal M; Curé H; Bordigoni P; Sutton L; Buzyn-Veil A; Tilly M; Keoirruer N; Feguex N Br J Haematol; 2000 Feb; 108(2):400-7. PubMed ID: 10691873 [TBL] [Abstract][Full Text] [Related]
38. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience. Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482 [TBL] [Abstract][Full Text] [Related]
39. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia. Byrne JL; Stainer C; Cull G; Haynes AP; Bessell EM; Hale G; Waldmann H; Russell NH Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585 [TBL] [Abstract][Full Text] [Related]
40. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]